KRd vs VRd as Induction Therapy in Newly Diagnosed High-Risk Multiple Myeloma

Episode 2 - Integrating Quadruplet Regimens in Newly Diagnosed Multiple Myeloma: Patient Focused ...Подробнее

Integrating Quadruplet Regimens in Newly Diagnosed Multiple MyelomaПодробнее

KRD vs VRD in high-risk multiple myeloma prior to autoHSCTПодробнее

IMWG Conference Series: Reporting from ASH 2022Подробнее

Oncology beyond the Obvious Webinar Series 2Подробнее

KRd vs VRd for initial therapy of newly diagnosed multiple myelomaПодробнее

COMy Online 2020 - Session 8 & 9Подробнее

ENDURANCE trial: KRd versus VRd for initial therapy of NDMMПодробнее